$202.61+4.61 (+2.33%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$204.00+1.39 (+0.69%)
After hours: Nov 17, 2026, 6:51 PM ET
Illumina (ILMN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 0.7% in FY25, net margin 19.6%, and free cash flow (~$931.0M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($M)▼0.7%
4,343.0
FY21→FY25CAGR −1.0%/yr
Net income ($M)—
850.0
one-off year: see footnoteCAGR +2.8%/yr
Free cash flow ($M)▲31.3%
931.0
FY21→FY25CAGR +28.9%/yr
Diluted EPS—
5.45
FY21→FY25CAGR +2.0%/yr
What the receipts whisper · what a headline number hides
Share count
+3.3%
151.0mn → 156.0mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$148.0M
+15.6% YoY in FY25 · 3.4% of revenue.
Returns vs FCF
80%
$743.0M returned vs $931.0M of FCF in FY25. Buybacks + dividends covered by cash flow.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
20¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 69.7% → 66.1%. Net margin 19.6% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 4,538.0 | 4,343.0 | 4,372.0 | 4,504.0 | 4,584.0 | 4,526.0 | ▼0.7% | −1.0% |
Cost of revenue | 1,458.0 | 1,473.0 | 1,511.0 | 1,760.0 | 1,612.0 | 1,372.0 | ▼2.5% | +1.8% |
Gross profit | 3,080.0 | 2,870.0 | 2,861.0 | 2,744.0 | 2,972.0 | 3,154.0 | ▲0.3% | −2.3% |
Research & development | 975.0 | 967.0 | 1,169.0 | 1,354.0 | 1,321.0 | 1,185.0 | ▼17.3% | −5.0% |
Selling, general & admin | 1,134.0 | 1,086.0 | 1,092.0 | 1,612.0 | 1,297.0 | 2,092.0 | ▼0.5% | −15.1% |
Total operating expenses | 2,119.0 | 2,063.0 | 3,694.0 | 3,813.0 | 7,151.0 | 3,277.0 | ▼44.2% | −10.9% |
Operating incomefeeds ROC rank | 961.0 | 807.0 | −833.0 | −1,069.0 | −4,179.0 | −123.0 | — | — |
Other income, net | 98.0 | 279.0 | −346.0 | −48.0 | −157.0 | 1,007.0 | — | — |
Pretax income | 1,059.0 | 1,086.0 | −1,179.0 | −1,117.0 | −4,336.0 | 884.0 | — | +5.3% |
Income tax | 164.0 | 236.0 | 44.0 | 44.0 | 68.0 | 122.0 | ▲436.4% | +17.9% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 895.0 | 850.0 | −1,223.0 | −1,161.0 | −4,404.0 | 762.0 | — | +2.8% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 5.93 | 5.45 | −7.69 | −7.34 | −28.00 | 5.04 | — | +2.0% |
Diluted shares (mn) | 154.00 | 156.00 | 159.00 | 158.00 | 157.00 | 151.00 | ▼1.9% | +0.8% |
| Margins | ||||||||
Gross margin52nd pct in Healthcare | 67.9% | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% | ▲0.6pp | −3.6pp |
Operating margin | 21.2% | 18.6% | −19.1% | −23.7% | −91.2% | −2.7% | ▲37.6pp | +21.3pp |
Net margin84th pct in Healthcare | 19.7% | 19.6% | −28.0% | −25.8% | −96.1% | 16.8% | ▲47.5pp | +2.7pp |
† TTM = trailing four quarters through 2026-09-27.FY21 effective tax rate was 14% vs a −2% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was 22% vs a −2% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Illumina's revenue last fiscal year?
Illumina reported revenue of $4,343.0M in fiscal 2025, down 0.7% from fiscal 2024.
What was Illumina's net income?
Illumina reported net income of $850.0M in fiscal 2025, a net margin of 19.6%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

